|Articles|November 15, 2018

Synteract Acquires Pediatric CRO KinderPharm

Synteract, a CRO, has acquired KinderPharm, a pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. Together, Synteract and KinderPharm will deliver a single source model for preclinical and clinical development, along with the operational and logistical understanding required in working with children and their families.

Read the full release here.


Related to this article